Abstract | AIM: METHODS: RESULTS: Per-protocol and intention-to-treat eradication rates were 77.7% and 70% in RAM group and 83.8% and 68.9% in OAM group (p = non significant). At both the 6th week and at the first year after treatment, the mean symptom scores were lower than pre-treatment scores in the study population, regardless of whether treatment was successful or not. However, patients, whether eradicated successfully or not-eradicated, presented similar 6-week and 1-year scores. CONCLUSIONS: One-week RAM triple therapy, which is cheaper than the OAM regimen, is a relatively effective alternative regimen for Helicobacter pylori eradication in Taiwanese. Triple therapy for Helicobacter pylori eradication was not the whole management for the relief of dyspeptic symptoms of non- ulcer dyspepsia patients.
|
Authors | C H Chuang, B S Sheu, H B Yang, J J Wu, X Z Lin |
Journal | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
(Dig Liver Dis)
Vol. 33
Issue 2
Pg. 125-30
(Mar 2001)
ISSN: 1590-8658 [Print] Netherlands |
PMID | 11346139
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Metronidazole
- Amoxicillin
- Ranitidine
- Omeprazole
|
Topics |
- Adult
- Amoxicillin
(administration & dosage)
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Dyspepsia
(drug therapy, microbiology)
- Female
- Follow-Up Studies
- Helicobacter Infections
(diagnosis, drug therapy)
- Helicobacter pylori
(drug effects, isolation & purification)
- Humans
- Male
- Metronidazole
(administration & dosage)
- Middle Aged
- Omeprazole
(administration & dosage)
- Probability
- Ranitidine
(administration & dosage)
- Reference Values
- Treatment Outcome
|